Skip to main content
. 2023 Mar 27;41(3):724–733. doi: 10.5534/wjmh.220216

Table 4. Association between EF one year before the interview and PCa according to urinary symptomatology in CAPLIFE study.

Urinary symptomatology EF (ejaculations/mo) Model 1 Model Model 3
Without >4 Reference
4 1.29 (0.66–2.54) 1.33 (0.67–2.64) 1.41 (0.68–2.93)
0–3 1.67 (0.93–3.01) 1.69 (0.93–3.06) 2.09 (1.10–3.97)
p–trend 0.075 0.079 0.018
Mild >4 Reference
4 1.16 (0.65–2.06) 1.16 (0.64–2.08) 1.26 (0.66–2.39)
0–3 1.62 (0.98–2.67) 1.65 (1.00–2.74) 1.93 (1.11–3.36)
p–trend 0.045 0.037 0.013
Moderate >4 Reference
4 2.27 (1.08–4.78) 2.37 (1.12–5.02) 2.62 (1.18–5.80)
0–3 3.13 (1.60–6.11) 3.43 (1.73–6.78) 3.83 (1.84–7.95)
p–trend 0.001 0.001 0.001
Severe >4 Reference
4 2.33 (0.56–9.71) 2.39 (0.56–10.12) 2.42 (0.57–10.26)
0–3 3.26 (0.91–11.76) 3.19 (0.87–11.61) 3.09 (0.84–11.39)
p-trend 0.065 0.077 0.090

Values are presented as adjusted odds ratio (95% confidence interval).

EF: ejaculation frequency, PCa: prostate cancer.

Model 1: adjusted for age, educational level, and first-degree family history of PCa.

Model 2: adjusted for age, educational level, first-degree family history of PCa, height, sedentary behavior, diabetes mellitus, and vasectomy.

Model 3: adjusted for age, educational level, first-degree family history of PCa, height, sedentary behavior, diabetes mellitus, vasectomy, energy intake and alcohol consumption.